We are live on ! Find out more
AIM

Advantage Investment Management Portfolio holdings

AUM $128M
1-Year Est. Return 0.94%
This Fund
S&P 500
This Quarter Est. Return
+3.81%
1 Year Est. Return
+0.94%
3 Year Est. Return
+28.59%
5 Year Est. Return
+40.78%
10 Year Est. Return
AUM
$253M
AUM Growth
-$17.8M
Cap. Flow
-$26.8M
Cap. Flow %
-10.6%
Top 10 Hldgs %
29.49%
Holding
1,087
New
106
Increased
276
Reduced
238
Closed
96
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACCO icon
851
Acco Brands
ACCO
$402M
$3K ﹤0.01%
+191
New +$2.48K
ADM icon
852
Archer Daniels Midland
ADM
$37.4B
$3K ﹤0.01%
66
-1,372
-95% -$61.5K
ANIP icon
853
ANI Pharmaceuticals
ANIP
$1.82B
$3K ﹤0.01%
62
ARTW icon
854
Arts-Way Manufacturing Co
ARTW
$11.5M
$3K ﹤0.01%
910
ATHE
855
Alterity Therapeutics
ATHE
$79.2M
$3K ﹤0.01%
112
AX icon
856
Axos Financial
AX
$5.89B
$3K ﹤0.01%
100
AZN icon
857
AstraZeneca
AZN
$250B
$3K ﹤0.01%
50
CPRX
858
DELISTED
Catalyst Pharmaceutical
CPRX
$3K ﹤0.01%
1,500
CSL icon
859
Carlisle Companies
CSL
$15.3B
$3K ﹤0.01%
30
DFS
860
DELISTED
Discover Financial Services
DFS
$3K ﹤0.01%
37
DOC icon
861
Healthpeak Properties
DOC
$15B
$3K ﹤0.01%
104
+1
+1% +$31
EIRL icon
862
iShares MSCI Ireland ETF
EIRL
$77.1M
$3K ﹤0.01%
66
ENZL icon
863
iShares MSCI New Zealand ETF
ENZL
$83.6M
$3K ﹤0.01%
63
EPHE icon
864
iShares MSCI Philippines ETF
EPHE
$145M
$3K ﹤0.01%
84
FTA icon
865
First Trust Large Cap Value AlphaDEX Fund
FTA
$1.4B
$3K ﹤0.01%
62
LH icon
866
Labcorp
LH
$25.4B
$3K ﹤0.01%
23
MD icon
867
Pediatrix Medical
MD
$2.13B
$3K ﹤0.01%
36
MNST icon
868
Monster Beverage
MNST
$92.4B
$3K ﹤0.01%
132
MSM icon
869
MSC Industrial Direct
MSM
$7.01B
$3K ﹤0.01%
34
NDSN icon
870
Nordson
NDSN
$17.3B
$3K ﹤0.01%
22
NTCT icon
871
NETSCOUT
NTCT
$2.98B
$3K ﹤0.01%
86
PBI icon
872
Pitney Bowes
PBI
$2.51B
$3K ﹤0.01%
200
PHG icon
873
Philips
PHG
$26B
$3K ﹤0.01%
139
PPC icon
874
Pilgrim's Pride
PPC
$6.33B
$3K ﹤0.01%
143
PRLB icon
875
Protolabs
PRLB
$2.16B
$3K ﹤0.01%
64

Similar funds

Advantage Investment Management's Q1 2017 Portfolio in Review

As of Q1 2017, Advantage Investment Management held 1,087 positions worth $253M, down 6.6% from $270M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Advantage Investment Management withdrew a net $26.8M in Q1 2017, closing 96 positions and reducing 238 holdings. Its most notable exit was Invesco Emerging Markets Sovereign Debt ETF, an estimated $3.73M position sold in full.

By sector, the portfolio is most concentrated in Financials at 8.2% of assets, up from 7.1% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Advantage Investment Management opened a new position in State Street SPDR Bloomberg 1-3 Month T-Bill ETF worth $4.09M.

  • Advantage Investment Management's largest Q1 2017 buy was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 44,699 shares worth $4.09M.
  • Advantage Investment Management added most to iShares MSCI USA Quality Factor ETF in Q1 2017, an estimated $7.33M increase.
  • Advantage Investment Management's biggest Q1 2017 reduction was State Street SPDR Bloomberg Convertible Securities ETF, cutting an estimated $9.86M.
  • Advantage Investment Management fully exited Invesco Emerging Markets Sovereign Debt ETF in Q1 2017, selling an estimated $3.73M.
  • Advantage Investment Management's ten largest holdings make up 29% of its $253M portfolio in Q1 2017.
  • Advantage Investment Management opened 106 new positions and closed 96 in Q1 2017.
  • Advantage Investment Management's portfolio value fell 6.6% quarter-over-quarter to $253M.

Based on Advantage Investment Management's 13F filing for Q1 2017, filed 8 May 2017.